PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results

PTCT 10.24.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-07
Name of Upcoming Event:webcast conference call
Full Press ReleaseSEC FilingsOur PTCT Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 01.13.2025 - 2025 J.P. Morgan Healthcare Conference
  • 01.13.2025 - PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.10.2025 - 144 Report of proposed sale of securities

WARREN, N.J.,Oct. 24, 2024/PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2024 financial results and provide an update on the company's business and outlook onThursday, Nov. 7, at4:30 p.m. EST.

To access the call by phone, pleaseclick hereto register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website athttps://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

AboutPTC Therapeutics, Inc.PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us atwww.ptcbio.comand follow us on Facebook, on X (formerly Twitter), and on LinkedIn.

For More Information:

Investors:Investor Relations+1 (908) 912-9848ir@ptcbio.com

Media:Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com

CisionView original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-302285326.html

SOURCEPTC Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com